Related references
Note: Only part of the references are listed.AASLD guidelines for treatment of chronic hepatitis B
Norah A. Terrault et al.
HEPATOLOGY (2016)
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
S. K. Sarin et al.
HEPATOLOGY INTERNATIONAL (2016)
A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-NEGATIVE, CHRONIC HEPATITIS B: WEEK 48 EFFICACY AND SAFETY RESULTS
M. Buti et al.
JOURNAL OF HEPATOLOGY (2016)
A PHASE 3 STUDY OF TENOFOVIR ALAFENAMIDE COMPARED WITH TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HBV: WEEK 48 EFFICACY AND SAFETY RESULTS
H. L. Y. Chan et al.
JOURNAL OF HEPATOLOGY (2016)
The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine
Cristina Stasi et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients
Lourdes Mateo et al.
CLINICAL RHEUMATOLOGY (2016)
Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity
Meghan E. Sise et al.
AIDS (2015)
Effect of Nucleoside and Nucleotide Analogues on Renal Function in Patients With Chronic Hepatitis B Virus Monoinfection
Vincent Mallet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Tenofovir-associated Fanconi syndrome and nephrotic syndrome in a patient with chronic hepatitis B monoinfection
Hyeon Seok Hwang et al.
HEPATOLOGY (2015)
Glomerular Filtration Rate and Albuminuria for Detection and Staging of Acute and Chronic Kidney Disease in Adults A Systematic Review
Andrew S. Levey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Renal Function in Chronic Hepatitis B Patients Treated With Tenofovir Disoproxil Fumarate or Entecavir Monotherapy A Matched Case-Cohort Study
Nghi B. Ha et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan
Chi-Ling Chen et al.
JOURNAL OF HEPATOLOGY (2015)
PROACTIVE DOSE ADJUSTMENTS ARE NECESSARY IN MANY ADV-EXPERIENCED PATIENTS TREATED WITH TDF MONOTHERAPY FOR 5 YEARS: A PROSPECTIVE COHORT STUDY IN 320 PATIENTS
P. Lampertico et al.
JOURNAL OF HEPATOLOGY (2015)
Association of baseline vitamin D levels with clinical parameters and treatment outcomes in chronic hepatitis B
Henry Lik-Yuen Chan et al.
JOURNAL OF HEPATOLOGY (2015)
Failed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Manjeri A. Venkatachalam et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Long-term antiviral efficacy of entecavir and liver histology improvement in Chinese patients with hepatitis B virus-related cirrhosis
Yan Xu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B
Calvin Q. Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Management of patients with hepatitis B in special populations
Evangelos Cholongitas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Renal proximal tubular dysfunction due to tenofovir in a patient with chronic hepatitis B monoinfection
Soeradj Harkisoen et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B
S. Koklu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection
Maria Buti et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Long-Term Treatment with Tenofovir in Asian-American Chronic Hepatitis B Patients Is Associated with Abnormal Renal Phosphate Handling
Connie Tien et al.
DIGESTIVE DISEASES AND SCIENCES (2015)
Assessment of Bone Mineral Density in Tenofovir-Treated Patients With Chronic Hepatitis B: Can the Fracture Risk Assessment Tool Identify Those at Greatest Risk?
Upkar S. Gill et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Vitamin D Deficiency in Unselected Patients from Swiss Primary Care: A Cross-Sectional Study in Two Seasons
Christoph Merlo et al.
PLOS ONE (2015)
Prolonged use of tenofovir and entecavir in hepatitis B virus-related cirrhosis
Sundeep Goyal et al.
INDIAN JOURNAL OF GASTROENTEROLOGY (2015)
Letter: tenofovir is associated with higher probability of acute kidney injury compared with entecavir
T. -M. Chen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Tenofovir alafenamide is not a substrate for renal organic anion transporters (OATs) and does not exhibit OAT-dependent cytotoxicity
Rujuta A. Bam et al.
ANTIVIRAL THERAPY (2014)
Renal Function of Participants in the Bangkok Tenofovir Study-Thailand, 2005-2012
Michael Martin et al.
CLINICAL INFECTIOUS DISEASES (2014)
Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B
Edward J. Gane et al.
GASTROENTEROLOGY (2014)
ABCC2*1C and plasma tenofovir concentration are correlated to decreased glomerular filtration rate in patients receiving a tenofovir-containing antiretroviral regimen
Weerawat Manosuthi et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Tenofovir-induced Fanconi syndrome in chronic hepatitis B monoinfected patients that reverted after tenofovir withdrawal
Mauro Vigano et al.
JOURNAL OF CLINICAL VIROLOGY (2014)
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment
James Fung et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)
Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection
David M. Gracey et al.
ANTIVIRAL THERAPY (2013)
Association of AKI With Mortality and Complications in Hospitalized Patients With Cirrhosis
Justin M. Belcher et al.
HEPATOLOGY (2013)
TENOFOVIR DF (TDF) IS SAFE AND WELL TOLERATED IN CHRONIC HEPATITIS B (CHB) PATIENTS WITH PRE-EXISTING MILD RENAL IMPAIRMENT
S. Fung et al.
JOURNAL OF HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Renal tubular dysfunction during long-term adefovir or tenofovir therapy in chronic hepatitis B
N. Gara et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B
Robert G. Gish et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Long-term safety and tolerability of entecavir in patients with chronic hepatitis B in the rollover study ETV-901
Michael P. Manns et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Efficacy of Entecavir With or Without Tenofovir Disoproxil Fumarate for Nucleos(t)ide-Naive Patients With Chronic Hepatitis B
Anna S. Lok et al.
GASTROENTEROLOGY (2012)
Randomized, Placebo-Controlled Trial of Tenofovir Disoproxil Fumarate in Adolescents With Chronic Hepatitis
Karen F. Murray et al.
HEPATOLOGY (2012)
Severe vitamin D deficiency in a patient treated for hepatitis B with tenofovir
N. Kumar et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Recognizing and treating secondary osteoporosis
Karen Walker-Bone
NATURE REVIEWS RHEUMATOLOGY (2012)
Proximal renal tubular acidosis: a not so rare disorder of multiple etiologies
Syed K. Haque et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
Lesley A. Inker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lactic acidosis during Entecavir treatment in decompensated hepatitis B virus-related cirrhosis
Alfredo Marzano et al.
DIGESTIVE AND LIVER DISEASE (2011)
Drug safety evaluation of adefovir in HBV infection
Mauro Vigano et al.
EXPERT OPINION ON DRUG SAFETY (2011)
Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver Disease
Yun-Fan Liaw et al.
HEPATOLOGY (2011)
Chronic hepatitis B in Asia-new insights from the past decade
Henry Lik-Yuen Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)
Effect of HBV polymerase inhibitors on renal function in patients with chronic hepatitis B
Stefan Mauss et al.
JOURNAL OF HEPATOLOGY (2011)
Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B
Andrés Duarte-Rojo et al.
Therapeutic Advances in Gastroenterology (2010)
Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir
Pablo Labarga et al.
AIDS (2009)
Side Effects of Long-Term Oral Antiviral Therapy for Hepatitis B
Robert J. Fontana
HEPATOLOGY (2009)
Severe Lactic Acidosis During Treatment of Chronic Hepatitis B with Entecavir in Patients with Impaired Liver Function
Christian M. Lange et al.
HEPATOLOGY (2009)
Tenofovir-associated renal and bone toxicity
C. L. N. Woodward et al.
HIV MEDICINE (2009)
Fatal Lactic Acidosis Associated With the Use of Combination Oral Medications to Treat Reactivation of Hepatitis B
Stanley Martin Cohen et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)
Tenofovir-associated Fanconi syndrome: Review of the FDA adverse event reporting system
Samir K. Gupta
AIDS PATIENT CARE AND STDS (2008)
Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis B
Patrick Marcellin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B
TT Chang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
CL Lai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV
JE Gallant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Renal safety of adefovir dipivoxil in patients with chronic hepatitis B: Two double-blind, randomized, placebo-controlled studies
H Izzedine et al.
KIDNEY INTERNATIONAL (2004)
Efficacy and safety of tenofovir DF vs stavuldine in combination therapy in antiretroviral-naive patients - A 3-year randomized trial
JE Gallant et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial
EJ Fisher et al.
AIDS (2001)
Share Paper
